GWPH Key Stats
|Revenue (Quarterly YoY Growth)||Upgrade|
|EPS Diluted (TTM)||-1.728|
|EPS Diluted (Quarterly YoY Growth)||Upgrade|
|Net Income (TTM)||-28.93M|
|Gross Profit Margin (Quarterly)||91.56%|
|Profit Margin (Quarterly)||-91.03%|
|Dividend Yield (TTM)||0.00%|
|Payout Ratio (TTM)||Upgrade|
|11/26/2014||Earnings||GW Pharmaceuticals PLC Fourth Quarter Earnings Results in 2014|
|08/06/2014 08:00 EDT||Misc||GW Pharmaceuticals PLC 3Q2014 Earning Conference Call|
|08/06/2014||Earnings||GW Pharmaceuticals PLC 3Q2014 Earning Result|
|05/07/2014 08:00 EDT||Misc||GW Pharmaceuticals PLC Q2 2014 Earnings Conference Call|
|05/07/2014||Earnings||Q2 Results for GW Pharmaceuticals PLC|
|03/11/2014||Misc||GW Pharmaceuticals PLC 2013 Annual General Meeting|
|02/05/2014 08:00 EDT||Misc||Q1 2014 Financial Results & Conference Call|
|02/05/2014||Earnings||Q1 2014 Financial Results|
|11/26/2013||Misc||Annual Report for GW Pharmaceuticals PLC|
GWPH Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). GW Pharmaceuticals is up 126.7% over the last year vs S&P 500 Total Return up 17.29%, Abaxis up 52.52%, and ZELTIQ Aesthetics up 80.36%.
Income Statement View Statement
Balance Sheet View Statement
Y-Ratings for GWPH
PDF Report for GWPH
Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.Download GWPH Pro Report PDF
Portfolio Strategies Featuring GWPH
Did GW Pharmaceuticals make it into our Portfolio Strategies?
Start your YCharts membership now to find out.
- Sector: Healthcare
- Industry: Drug Manufacturers - Major
- Company Website: http://www.gwpharm.com
- IR Website: http://ir.gwpharm.com/
- HQ Country: United Kingdom
- HQ State/Province: N/A
- Incorporation Country: United Kingdom
- Incorporation State/Province: N/A
- Est. Current Fiscal Quarter End: December 31, 2014
- Est. Current Fiscal Year End: September 30, 2015
- Last Fiscal Quarter End: June 30, 2014
- Last Fiscal Year End: September 30, 2013
GW Pharmaceuticals PLC is engaged in the research, development and commercialisation of cannabinoid prescription medicines to meet patient needs in a wide range of medical conditions.
GWPH Excel Add-In Codes
- Name: =YCI("GWPH","name")
- Description: =YCI("GWPH","description")
- Sector: =YCI("GWPH","sector")
- Industry: =YCI("GWPH","industry")
- Est. Current Fiscal Year End: =YCI("GWPH","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.